Anti-CDKN2AIP antibody
4
(2 Reviews)
|
(3 Publications)
Rabbit Polyclonal CDKN2AIP antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human CDKN2AIP aa 1-50.
View Alternative Names
CARF, CDKN2AIP, CDKN2A-interacting protein, Collaborator of ARF
- IP
Unknown
Immunoprecipitation - Anti-CDKN2AIP antibody (AB140519)
Immunoprecipitation of CDKN2AIP from 293T whole cell lysate using ab140519 at 6 µg/mg lysate (1 mg of lysate for IP; 20% of IP loaded).
For blotting immunoprecipitated CDKN2AIP, ab140519 was used at 1 µg/ml.
Detection : chemiluminescence with an exposure time of 10 seconds.
All lanes:
Immunoprecipitation - Anti-CDKN2AIP antibody (ab140519)
Predicted band size: 61 kDa
false
- WB
Unknown
Western blot - Anti-CDKN2AIP antibody (AB140519)
All lanes:
Western blot - Anti-CDKN2AIP antibody (ab140519) at 0.4 µg/mL
Lane 1:
293T whole cell lysate at 50 µg
Lane 2:
293T whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 50 µg
Lane 4:
Jurkat whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 61 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein CDKN2AIP/CARF participates in modulating cellular response to DNA damage. It forms complexes with p53 and other regulators like HDM2 to control cell cycle checkpoints and apoptosis. This regulatory mechanism ensures cells with damaged DNA do not progress through the cell cycle reducing the risk of malignant transformations. Additionally CDKN2AIP/CARF influences the expression of genes associated with cellular aging and stress response impacting how a cell responds to various biological signals.
Pathways
CDKN2AIP/CARF influences the p53 signaling pathway a critical axis in maintaining genomic integrity. It partners with p53 essentially regulating cell cycle arrest senescence and apoptosis which is a protective measure against cancer development. CARF interacts closely with CDKN2A and other elements in the retinoblastoma protein (pRb) pathway highlighting its role in regulating cell division and ensuring proper cell cycle progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer 21:92 PubMed35366893
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 6:85 PubMed33298864
2020
Applications
Unspecified application
Species
Unspecified reactive species
Carcinogenesis 35:138-44 PubMed23985780
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com